Sonoma Pharmaceuticals (SNOA) EBT Margin: 2011-2012
Historic EBT Margin for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -58.02%.
- Sonoma Pharmaceuticals' EBT Margin rose 6671.00% to -26.95% in Q4 2012 from the same period last year, while for Dec 2012 it was -29.58%, marking a year-over-year increase of 2979.00%. This contributed to the annual value of -58.02% for FY2012, which is 2305.00% up from last year.
- Sonoma Pharmaceuticals' EBT Margin amounted to -58.02% in FY2012, which was up 28.44% from -81.07% recorded in FY2011.
- Over the past 5 years, Sonoma Pharmaceuticals' EBT Margin peaked at -58.02% during FY2012, and registered a low of -81.07% during FY2011.
- Moreover, its 2-year median value for EBT Margin was -69.55% (2011), whereas its average is -69.55%.
- Data for Sonoma Pharmaceuticals' EBT Margin shows a peak YoY surged of 2,305bps (in 2012) over the last 5 years.
- Yearly analysis of 2 years shows Sonoma Pharmaceuticals' EBT Margin stood at -81.07% in 2011, then soared by 2,305bps to -58.02% in 2012.